These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12853556)

  • 21. Heparin and protamine interaction.
    Blaise G
    Can J Anaesth; 1998 Dec; 45(12):1144-7. PubMed ID: 10051929
    [No Abstract]   [Full Text] [Related]  

  • 22. Adverse reactions to protamine.
    Horrow JC
    Int Anesthesiol Clin; 1985; 23(3):133-44. PubMed ID: 4030121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protamine: a review of its toxicity.
    Horrow JC
    Anesth Analg; 1985 Mar; 64(3):348-61. PubMed ID: 3883848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The total artificial heart. A better model to study the hemodynamic effect of protamine.
    De Paulis R; Mohammad SF; Riebman JB; Deleuze P; Morea M; Olsen DB
    ASAIO Trans; 1987; 33(3):217-21. PubMed ID: 3675947
    [No Abstract]   [Full Text] [Related]  

  • 27. A filter device for the prevention of both heparin- and protamine-induced complications associated with extracorporeal therapy.
    Yang VC; Teng CL; Kim JS
    Biomed Instrum Technol; 1990; 24(6):433-9. PubMed ID: 2261582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The most common secondary effects of protamine].
    Alvarez Escudero J; Villar Landeira JM
    Rev Esp Anestesiol Reanim; 1986; 33(5):349-55. PubMed ID: 3786892
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anaphylaxis to protamine during cardiovascular surgery].
    Madani H; Sadiki EO; Bouziane M; Amaarouch S; Madani M; Khatouf M
    Ann Pharm Fr; 2014 May; 72(3):143-5. PubMed ID: 24780829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamics and proteolysis in experimental trypsin induced shock.
    Naess F; Pillgram-Larsen J; Ruud TE; Stadaas JO; Aasen AO
    Prog Clin Biol Res; 1987; 236A():185-92. PubMed ID: 3649820
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of the nitric oxide pathway in refractory septic shock].
    Andresen M; Dougnac A; Hernández G; Espejo J; Castillo L; Bugedo G; Letelier LM; Dagnino J
    Rev Med Chil; 1996 Apr; 124(4):442-7. PubMed ID: 9110484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protamine-induced circulatory changes.
    Frater RW; Oka Y; Hong Y; Tsubo T; Loubser PG; Masone R
    J Thorac Cardiovasc Surg; 1984 May; 87(5):687-92. PubMed ID: 6609280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
    Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
    J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
    Wakefield TW; Whitehouse WM; Stanley JC
    J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case 3--2000. Improper administration of protamine during cardiopulmonary bypass.
    Karaaslan D; Akpek EA; Sekerci S; Arslan G; Stammers A
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):327-9. PubMed ID: 10890491
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged methylene blue infusion in refractory septic shock: a case report.
    Dumbarton TC; Minor S; Yeung CK; Green R
    Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of platelet-activating factor in the ovine heparin-protamine reaction.
    Montalescot G; Huerta JM; Braquet P; Zapol WM
    J Appl Physiol (1985); 1992 Dec; 73(6):2604-7. PubMed ID: 1490976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral mediators of catastrophic reactions associated with protamine neutralization.
    Colman RW
    Anesthesiology; 1987 May; 66(5):595-6. PubMed ID: 3578874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.